Taste Masking 101- Optimize Taste and Improve Patient Outcomes
Sponsored by: Adare Pharma Solutions and IFF
Date: 28 June
Days to go: 15
Time: 9AM EST / 2PM London / 3PM CET
Understanding Why Taste Masking is Critical to Patient Acceptability, Adherence and Successful Outcomes
Unpleasant taste is the biggest barrier for completing treatment in pediatrics and 30% to 40% of parents had children who rejected or refused a pill or liquid medication. 26% of geriatric patients reported difficulty swallowing tablets and capsules. By applying a taste masking application, patient compliance can increase 53% to 90%.
The correlation between taste masking and understanding the impact to patient adherence is critical for any successful treatment plan. In this 4-part webinar series, we will discuss: the challenges within the industry such as swallowability and palatability related to patient acceptability for oral drug formulations; Regulatory and critical insights for developing a taste masked therapeutic, and an overview of taste masking strategies and techniques. In future segments of the series, innovations regarding sensory and performance evaluations will be discussed.
In the first webinar of this series, you will learn how swallowability and palatability play key factors related to patient acceptability and product development. Learn about the variety of taste masking strategies including excipients, organoleptic and barrier coating approaches, and microencapsulation technologies. Learn how these applications optimize product development and can improve patient adherence, and ultimately can improve patient outcomes. Register to learn how to improve your products today.
Dr. Luigi Boltri,
Senior Director, Pharmaceutical Sciences, Adare Pharma Solutions
Dr. Boltri is a pharmaceutical chemist by training and completed his degree at the University of Turin.
With more than 30 years of experience in the Pharmaceutical Industry, Dr Boltri has held leading positions as Department Head and Director. Dr. Boltri has extensive experience in formulation development for various dosage forms, with a focus on oral delivery and bioavailability enhancement.
In the current role, Dr. Boltri supports Company processes leading to identify new and innovative technologies as well as valuable opportunities for product development and co-development.
Dr. Nasrin Mahmoudi,
Technical Manager, International Flavors and Fragrances (IFF) company
Nasrin is a member of the Application Development and Innovation (AD&I) team within Nutrition & Biosciences business division of the International Flavors and Fragrances (IFF) company. As a scientist and technical manager, Nasrin’s role is working with the pharmaceutical customers in the North American region to partner in product development. Nasrin provides technical information on application/regulatory aspects of the broad range of excipients and enables customers to troubleshoot and facilitate their formulation development process. Nasrin has PharmD and Ph.D. degrees from the Medical Sciences University of Tehran (Iran) followed by post-doctoral research at Rutgers University (NJ, US) and Pfizer Inc (NJ, & MI, US). Nasrin has a broad range of experiences in the pharmaceutical industry, particularly in solubility enhancement, immediate and controlled release dosage forms and taste masking of oral formulations.
Key Learning Objectives
- Learn about the challenges regarding developing an oral therapeutic
- Learn how taste, smell and texture impact palatability and patient acceptability
- Learn the mechanisms of swallowing and impact to patient adherence
- Learn about taste masking strategies, technologies and applications
- Senior/Principal Scientists
- Formulation Directors/Managers
- R&D Scouting technology Innovation Directors/Managers
- External Manufacturing Directors/Mangers
- CMC Directors/Managers
- Anyone involved in Outsourcing/ Procurement